SAT0206 Retention of tocilizumab as monotherapy versus tnf inhibitors with conventional synthetic dmards in rheumatoid arthritis patients with inadequate response to tnf inhibitors: a study from the tocerra collaboration
SAT0206 Retention of tocilizumab as monotherapy versus tnf inhibitors with conventional synthetic dmards in rheumatoid arthritis patients with inadequate response to tnf inhibitors: a study from the tocerra collaboration
PDF